In 222 patients with LVEF ≤35% undergoing high-risk PCI, a micro-axial flow pump (SynFlow 3.0) was non-inferior to VA-ECMO for 30-day major adverse events (7.34% vs 11.5%; difference −4.6%), with shorter hospital stay and fewer device-related events.
RCTn = 222
Zhao et al. Micro-axial flow pump vs veno-arterial extracorporeal membrane oxygenation for high-risk percutaneous coronary interventions: a randomized trial